Literature DB >> 18803359

Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Zhi-Tao Yang1, Xin-Xin Zhang, Xiao-Fei Kong, Dong-Hua Zhang, Shen-Ying Zhang, Jie-Hong Jiang, Qi-Ming Gong, Gen-Di Jin, Zhi-Meng Lu.   

Abstract

AIM: To identify the two polymorphisms of microsomal triglyceride transfer protein (MTP) gene in the Chinese population and to explore their correlation with both hepatitis B virus (HBV) self-limited infection and persistent infection.
METHODS: A total of 316 subjects with self-limited HBV infection and 316 patients with persistent HBV infection (195 subjects without familial history), matched with age and sex, from the Chinese Han population were enrolled in this study. Polymorphisms of MTP at the promoter region -493 and at H297Q were determined by the allele specific polymerase chain reaction (PCR).
RESULTS: The ratio of males to females was 2.13:1 for each group and the average age in the self-limited and chronic infection groups was 38.36 and 38.28 years, respectively. None of the allelic distributions deviated significantly from that predicted by the Hardy-Weinberg equilibrium. There was a linkage disequilibrium between H297Q and -493G/T (D' = 0.77). As the c2 test was used, the genotype distribution of MTP-493G/T demonstrated a significant difference between the self-limited infection group and the entire chronic group or the chronic patients with no family history (c2 = 8.543, P = 0.015 and c2 = 7.199, P = 0.019). The allele distribution at the MTP-493 position also demonstrated a significant difference between the study groups without family history (c2 = 6.212, P = 0.013). The T allele emerged as a possible protective factor which may influence the outcomes of HBV infection (OR: 0.59; 95% CI: 0.389-0.897).
CONCLUSION: The polymorphism of the MTP gene, T allele at -493, may be involved in determining the HBV infection outcomes, of which the mechanism needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803359      PMCID: PMC2744166          DOI: 10.3748/wjg.14.5454

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  53 in total

Review 1.  Chronic viral hepatitis and the human genome.

Authors:  C L Thio; D L Thomas; M Carrington
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes.

Authors:  S Bernard; S Touzet; I Personne; V Lapras; P J Bondon; F Berthezène; P Moulin
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

4.  Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis.

Authors:  J F Tsai; J E Jeng; M S Ho; W Y Chang; Z Y Lin; J H Tsai
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

5.  Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

Authors:  William Abbott; Edward Gane; Ingrid Winship; Stephen Munn; Colin Tukuitonga
Journal:  Immunogenetics       Date:  2007-01-09       Impact factor: 2.846

6.  A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels.

Authors:  F Karpe; B Lundahl; E Ehrenborg; P Eriksson; A Hamsten
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

7.  A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.

Authors:  T P Leren; L Ose; A Hamsten; F Karpe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

Review 8.  APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.

Authors:  N O Davidson; G S Shelness
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

9.  HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.

Authors:  T Höhler; G Gerken; A Notghi; R Lubjuhn; H Taheri; U Protzer; H F Löhr; P M Schneider; K H Meyer zum Büschenfelde; C Rittner
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

10.  A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection.

Authors:  T Höhler; A Kruger; G Gerken; P M Schneider; K H Meyer zum Büschenefelde; C Rittner
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

View more
  3 in total

1.  A new polymorphism in the GRP78 is not associated with HBV invasion.

Authors:  Xiao Zhu; Yi Wang; Tao Tao; Dong-Pei Li; Fei-Fei Lan; Wei Zhu; Dan Xie; Hsiang-Fu Kung
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

2.  Microsomal triglyceride transfer protein gene -493G/T polymorphism and its association with serum lipid levels in Bama Zhuang long-living families in China.

Authors:  Shang-Ling Pan; Xiao-Qiu Luo; Ze-Ping Lu; Shao-Hua Lu; Huan Luo; Cheng-Wu Liu; Cai-You Hu; Ming Yang; Li-Li Du; Zhen Song; Guo-Fang Pang; Hua-Yu Wu; Jin-Bo Huang; Jun-Hua Peng; Rui-Xing Yin
Journal:  Lipids Health Dis       Date:  2012-12-28       Impact factor: 3.876

3.  A polymorphism in the microsomal triglyceride transfer protein can predict the response to antiviral therapy in Egyptian patients with chronic hepatitis C virus genotype 4 infection.

Authors:  Yasmin Saad; Olfat Shaker; Yasser Nassar; Lama Ahmad; Mohamed Said; Gamal Esmat
Journal:  Gut Liver       Date:  2014-10-07       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.